Dihydropyridine compounds and their use in reducing blood sugar
    4.
    发明授权
    Dihydropyridine compounds and their use in reducing blood sugar 失效
    二氢吡啶化合物及其在降血糖中的应用

    公开(公告)号:US4786641A

    公开(公告)日:1988-11-22

    申请号:US87491

    申请日:1987-08-20

    CPC分类号: C07D491/04 C07D211/90

    摘要: Blood-sugar-lowering dihydropyridines of the formula ##STR1## in which R.sup.1 represents phenyl, naphthyl, thienyl, pyridyl, chromenyl or thiochromenyl, it being possible for the radicals mentioned each to carry up to 2 identical or different substituents from the series comprising halogen, alkyl, alkoxy and alkylthio with in each case up to 6 carbon atoms, fluoroalkyl and fluoroalkoxy with in each case up to 3 carbon atoms and 3 fluorine atoms, nitro and cyano,R.sup.2 represents straight-chain, branched or cyclic alkyl which has up to 8 carbon atoms, can be interrupted in the alkyl chain by an oxygen or a sulphur atom and can be substituted by halogen, phenyl, cyano, hydroxyl, amino, alkylamino or dialkylamino with in each case up to 3 carbon atoms per alkyl group or by N-benzylmethylamino,R.sup.3 represents straight-chain, branched or cyclic alkyl which has up to 6 carbon atoms, can be interrupted in the alkyl chain by an oxygen atom and can be substituted by halogen, hydroxyl, amino, phenyl, morpholino, carboxy or alkoxycarbonyl with up to 4 carbon atoms andR.sup.4 and R.sup.5 each represent hydroxyl, orR.sup.4 and R.sup.5 together represent --O--,or a physiologically acceptable salt thereof.

    摘要翻译: 其中R1代表苯基,萘基,噻吩基,吡啶基,色烯基或硫代色烯基的式“IMAGE”的降血糖二氢吡啶类,各自所提及的基团有可能从包含卤素的系列中携带多达2个相同或不同的取代基 ,烷基,烷氧基和烷硫基,在每种情况下最多6个碳原子,氟代烷基和氟代烷氧基,在每种情况下最多3个碳原子和3个氟原子,硝基和氰基,R2表示直链,支链或环状的烷基, 至8个碳原子,可以通过氧或硫原子在烷基链中被中断,并且可以被卤素,苯基,氰基,羟基,氨基,烷基氨基或二烷基氨基取代,在每种情况下,每个烷基最多为3个碳原子,或 通过N-苄基甲基氨基,R3表示具有多至6个碳原子的直链,支链或环状烷基,可以在烷基链中被氧原子中断,并可被卤素,羟基,氨基,苯基, 具有至多4个碳原子的直链,羧基或烷氧基羰基,且R 4和R 5各自表示羟基,或者R 4和R 5一起表示-O-或其生理上可接受的盐。

    Substituted 1,8-naphthyridines and their use in medicaments
    10.
    发明授权
    Substituted 1,8-naphthyridines and their use in medicaments 失效
    取代的1,8-萘啶并用于药物

    公开(公告)号:US5034399A

    公开(公告)日:1991-07-23

    申请号:US496757

    申请日:1990-03-21

    CPC分类号: C07D471/04

    摘要: Inhibitors of 3-hydrooxy-3-methyl-glutarylcoenzyme A reductase which are 1,8-naphthyridines of the formula ##STR1## in which Arepresents a 3- to 7-membered heterocycle which is optionally substituted, or aryl which is optionally substituted,Brepresents cycloalkyl or alkyl which is optionally substituted, aryl which is optionally substituted,D and E are identical or different andrepresents hydrogen, halogen, mercapto, hydroxyl, alkoxy, alkyl which is optionally substituted, or a group of the formula --NR.sup.1 R.sup.2, aryl, aryloxy or arylthio having 6 to 10 carbon atoms, which is optionally substituted,Yrepresents a group of the formula ##STR2## in which Jdenotes hydrogen, hydroxyl, mercapto or halogen, or alkyl, alkoxy or alkylthio which are optionally substituted, aryloxy, benzyloxy or arylthio or a group of the formula --NR.sup.1 R.sup.2,Zdenotes oxygen or sulphur,Gdenotes hydrogen, alkyl or alkenyl which is optionally substituted,Xrepresents a group of the formula --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--,andRrepresents a group of the formula ##STR3## in which R.sup.5denotes hydrogen or alkyl, andR.sup.6denotes hydrogen or alkyl, which may be substituted by phenyl, ordenotes aryl or a cation,and their salts.

    摘要翻译: 作为式“IMAGE”的1,8-萘啶的3-羟基-3-氧代-3-甲基 - 戊二酰辅酶A还原酶的抑制剂,其中A表示任选取代的3-至7-元杂环,或任选取代的芳基, B代表任选取代的环烷基或烷基,任选取代的芳基,D和E相同或不同,代表氢,卤素,巯基,羟基,烷氧基,任选被取代的烷基,或式-NR1R2的基团, 芳基,芳氧基或具有6至10个碳原子的芳硫基,其任选被取代,Y表示下式的基团,其中J表示氢,羟基,巯基或卤素,或任选被取代的烷基,烷氧基或烷硫基, 芳氧基,苄氧基或芳硫基或式-NR1R2的基团,Z表示氧或硫,G表示氢,任选被取代的烷基或烯基,X表示式-CH 2 -CH 2 - 或-CH = CH- ,和R 表示式为“IMAGE”的基团,其中R5表示氢或烷基,R6表示氢或可被苯基取代的烷基,或表示芳基或阳离子及其盐。